EICHOR
● Active Not Recruiting
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Condition: Relapsed/Refractory Follicular Lymphoma · Marginal Zone Lymphoma · Sponsor: BeOne Medicines
About this study
The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R\^2) in participants with relapsed/refractory (R/R) follicular lymphoma (FL), as measured by progression-free survival as determined by an independent review committee in accordance with the 2014 modification of the International Working Group on non-Hodgkin lymphoma (NHL) Criteria based on n positron emission tomography and computed tomography (PET/CT), and to compare the efficacy of zanubrutinib plus rituximab versus R\^2 in participants with R/R marginal zone lymphoma (MZL), as measured by progression free survival (PFS) assessed by IRC in accordance with CT-based Lugano 2014 Criteria.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (270)
| Ucsf Fresno University of California San Francisco Fresno | Fresno, California, United States | — |
| Kaiser Permanente Southern California | Irvine, California, United States | — |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | — |
| Los Angeles Cancer Network | Los Angeles, California, United States | — |
| Valkyrie Clinical Trials | Los Angeles, California, United States | — |
| UCLA Hematologyoncology | Los Angeles, California, United States | — |
| Scripps Health | San Diego, California, United States | — |
| Sharp Healthcare Sharp Memorial Hospital | San Diego, California, United States | — |
| Baptist Md Anderson Cancer Center | Jacksonville, Florida, United States | — |
| Ascension Sacred Heart | Pensacola, Florida, United States | — |
| Northwest Georgia Oncology Centers Marietta | Marietta, Georgia, United States | — |
| Cancer Care Specialists of Illinois | Decatur, Illinois, United States | — |
+ 258 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05100862